CN1395487A - 米氮平用于治疗睡眠障碍的用途 - Google Patents

米氮平用于治疗睡眠障碍的用途 Download PDF

Info

Publication number
CN1395487A
CN1395487A CN01803934A CN01803934A CN1395487A CN 1395487 A CN1395487 A CN 1395487A CN 01803934 A CN01803934 A CN 01803934A CN 01803934 A CN01803934 A CN 01803934A CN 1395487 A CN1395487 A CN 1395487A
Authority
CN
China
Prior art keywords
mirtazapine
sleep
treatment
sleep disorders
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01803934A
Other languages
English (en)
Chinese (zh)
Inventor
G·S·F·鲁伊格特
F·范丹伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of CN1395487A publication Critical patent/CN1395487A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN01803934A 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途 Pending CN1395487A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499.2 2000-02-11
EP00200499 2000-02-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100056868A Division CN101229170A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Publications (1)

Publication Number Publication Date
CN1395487A true CN1395487A (zh) 2003-02-05

Family

ID=8171013

Family Applications (2)

Application Number Title Priority Date Filing Date
CN01803934A Pending CN1395487A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途
CNA2008100056868A Pending CN101229170A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2008100056868A Pending CN101229170A (zh) 2000-02-11 2001-02-06 米氮平用于治疗睡眠障碍的用途

Country Status (25)

Country Link
US (1) US6933293B2 (cg-RX-API-DMAC7.html)
EP (4) EP2283840A1 (cg-RX-API-DMAC7.html)
JP (1) JP5039994B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020069371A (cg-RX-API-DMAC7.html)
CN (2) CN1395487A (cg-RX-API-DMAC7.html)
AR (1) AR027394A1 (cg-RX-API-DMAC7.html)
AT (1) ATE317261T1 (cg-RX-API-DMAC7.html)
AU (1) AU780439B2 (cg-RX-API-DMAC7.html)
BR (1) BR0108261A (cg-RX-API-DMAC7.html)
CA (1) CA2396209C (cg-RX-API-DMAC7.html)
CO (1) CO5271706A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ302368B6 (cg-RX-API-DMAC7.html)
DE (1) DE60117122T2 (cg-RX-API-DMAC7.html)
DK (1) DK1257278T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258071T3 (cg-RX-API-DMAC7.html)
HK (1) HK1049122B (cg-RX-API-DMAC7.html)
HU (1) HUP0204391A3 (cg-RX-API-DMAC7.html)
IL (2) IL150290A0 (cg-RX-API-DMAC7.html)
NO (1) NO328007B1 (cg-RX-API-DMAC7.html)
PE (1) PE20011080A1 (cg-RX-API-DMAC7.html)
PL (1) PL206073B1 (cg-RX-API-DMAC7.html)
RU (1) RU2270680C2 (cg-RX-API-DMAC7.html)
SK (1) SK287396B6 (cg-RX-API-DMAC7.html)
WO (1) WO2001058453A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205238B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US20070298107A1 (en) * 2003-11-25 2007-12-27 Aurobindo Pharma Ltd. Pharmaceutical Compositions of Mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
WO2006041158A1 (ja) * 2004-10-14 2006-04-20 Daikin Industries, Ltd. 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
AR066005A1 (es) 2007-04-11 2009-07-15 Organon Nv Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclica
ES2874549T3 (es) 2015-02-27 2021-11-05 Dechra Ltd Estimulación del apetito, control de la pérdida de peso, y tratamiento de la anorexia en perros y gatos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
ATE148443T1 (de) * 1992-10-07 1997-02-15 Akzo Nobel Nv Verfahren zur trennung von enantiomeren aus einer racemischen mischung
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP1030667B1 (en) * 1997-11-14 2005-03-02 Akzo Nobel N.V. Use of mirtazapine for the manufacture of a medicament for treating sleep apneas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Also Published As

Publication number Publication date
PL206073B1 (pl) 2010-06-30
RU2002124141A (ru) 2004-03-10
AU780439B2 (en) 2005-03-24
AU3024701A (en) 2001-08-20
ZA200205238B (en) 2003-09-29
JP2003522147A (ja) 2003-07-22
US20030022888A1 (en) 2003-01-30
ES2258071T3 (es) 2006-08-16
HUP0204391A2 (en) 2003-05-28
HUP0204391A3 (en) 2005-03-29
DE60117122D1 (de) 2006-04-20
JP5039994B2 (ja) 2012-10-03
DK1257278T3 (da) 2006-06-12
EP1257278A1 (en) 2002-11-20
EP1656937A1 (en) 2006-05-17
NO20023803D0 (no) 2002-08-09
AR027394A1 (es) 2003-03-26
BR0108261A (pt) 2003-03-05
HK1049122A1 (en) 2003-05-02
RU2270680C2 (ru) 2006-02-27
EP2283840A1 (en) 2011-02-16
WO2001058453A1 (en) 2001-08-16
IL150290A0 (en) 2002-12-01
CN101229170A (zh) 2008-07-30
EP1257278B1 (en) 2006-02-08
CA2396209C (en) 2009-09-01
HK1049122B (en) 2006-04-21
DE60117122T2 (de) 2006-07-27
CZ302368B6 (cs) 2011-04-13
EP1658850A1 (en) 2006-05-24
SK11442002A3 (sk) 2003-02-04
KR20020069371A (ko) 2002-08-30
PL356721A1 (en) 2004-06-28
ATE317261T1 (de) 2006-02-15
IL150290A (en) 2010-12-30
NO20023803L (no) 2002-10-09
PE20011080A1 (es) 2001-10-18
US6933293B2 (en) 2005-08-23
CA2396209A1 (en) 2001-08-16
NO328007B1 (no) 2009-11-09
CO5271706A1 (es) 2003-04-30
SK287396B6 (sk) 2010-08-09
CZ20022330A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
Gillin et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial
EP1001760B1 (en) Composition for controlling mood disorders in healthy individuals
Ware et al. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients
KR101841442B1 (ko) 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
US20130150434A1 (en) Methods of using low-dose doxepin for the improvement of sleep
WO2007136845A2 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
CN1395487A (zh) 米氮平用于治疗睡眠障碍的用途
JPS63243028A (ja) 基本的うつ病を軽減するためのうつ病治療剤
US20060020037A1 (en) Tazarotenic acid and esters thereof for treating autism
EP1425026B1 (en) Valeriana officinalis extract for treating sleep-induced apnea or hypopnea
HK1087356A (en) The use of mirtazapine for the treatment of sleep disorders
HK1087359A (en) The use of mirtazapine for the treatment of sleep disorders
HK1150978A (en) The use of mirtazapine for the treatment of sleep disorders
TWI297607B (en) The use of mirtazapine for the treatment of sleep disorders and pharmaceutical composition comprising mirtazapine
MXPA02006710A (en) The use of mirtazapine for the treatment of sleep disorders
JPH03246225A (ja) メランコリーうつ病の治療法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ORGANON NV

Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP.

Effective date: 20070309

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20070309

Address after: Holland

Applicant after: Organon NV

Address before: Holland Arnhem

Applicant before: Akzo Nobel N. V.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication